Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 45,871 | 37,958 | 20,042 | 7,680 | 12,500 |
| Cost of Goods | 2,100 | 1,279 | 885 | N/A | N/A |
| Gross Profit | 43,771 | 36,679 | 19,157 | 6,854 | 12,500 |
| Operating Expenses | 101,297 | 106,311 | 103,799 | 104,045 | 102,077 |
| Operating Income | -57,426 | -69,353 | -83,757 | -96,365 | -89,577 |
| Interest Expense | 8,283 | 7,858 | 8,051 | 4,806 | 23 |
| Other Income | 4,994 | 5,364 | 6,962 | 7,002 | 5,474 |
| Pre-tax Income | -60,715 | -71,847 | -84,846 | -94,169 | -84,126 |
| Net Income Continuous | -60,715 | -71,847 | -84,846 | -94,169 | -84,126 |
| Net Income | $-60,715 | $-71,847 | $-84,846 | $-94,169 | $-84,126 |
| EPS Basic Total Ops | -0.70 | -0.83 | -0.98 | -1.09 | -0.98 |
| EPS Basic Continuous Ops | -0.70 | -0.83 | -0.98 | -1.09 | -0.98 |
| EPS Diluted Total Ops | -0.70 | -0.83 | -0.98 | -1.09 | -0.98 |
| EPS Diluted Continuous Ops | -0.70 | -0.83 | -0.98 | -1.09 | -0.98 |
| EPS Diluted Before Non-Recurring Items | -0.70 | -0.83 | -0.98 | -1.10 | -0.98 |
| EBITDA(a) | $-59,774 | $-72,509 | $-87,244 | $-99,275 | $-92,633 |